- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
When Should Open-Label Extension Studies Be Stopped?
American Journal of Bioethics 14 (4):57-58 (2014)
Abstract
No abstractAuthor's Profile
Other Versions
No versions found
My notes
Similar books and articles
Ethics of Continuing to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”.Holly A. Taylor, Ellen Kuwana & Benjamin S. Wilfond - 2014 - American Journal of Bioethics 14 (4):56-56.
The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”.Ryan R. Nash - 2014 - American Journal of Bioethics 14 (4):59-60.
Design, objectives, execution and reporting of published open‐label extension studies.Bowers Megan, Ruth M. Pickering & Mark Weatherall - 2012 - Journal of Evaluation in Clinical Practice 18 (2):209-215.
Open label extension studies and patient selection biases.Karla Hemming, Jane L. Hutton, Melissa J. Maguire & Anthony G. Marson - 2008 - Journal of Evaluation in Clinical Practice 14 (1):141-144.
Consent to open label extension studies: some ethical issues.P. Wainwright - 2002 - Journal of Medical Ethics 28 (6):373-376.
Open Label Extension Studies & the Ethical Design of Clinical Trials.David Casarett, Jason Karlawish, Pamela Sankar, Karen B. Hirschman & David A. Asch - 2001 - IRB: Ethics & Human Research 23 (4):1.
When "risk" and "benefit" are open to interpretation - as is generally the case.Merle Spriggs - 2007 - American Journal of Bioethics 7 (3):17 – 19.
Ethical Management of Diagnostic Uncertainty: Response to Open Peer Commentaries on “Why Bioethics Should Be Concerned With Medically Unexplained Symptoms”.Diane O’Leary - 2018 - American Journal of Bioethics 18 (8):W6-W11.
Analytics
Added to PP
2014-04-15
Downloads
27 (#686,285)
6 months
16 (#287,068)
2014-04-15
Downloads
27 (#686,285)
6 months
16 (#287,068)
Historical graph of downloads
Author's Profile
References found in this work
A Critique of Clinical Equipoise: Therapeutic Misconception in the Ethics of Clinical Trials.Franklin G. Miller & Howard Brody - 2003 - Hastings Center Report 33 (3):19-28.
Consent to open label extension studies: some ethical issues.P. Wainwright - 2002 - Journal of Medical Ethics 28 (6):373-376.
Open Label Extension Studies & the Ethical Design of Clinical Trials.David Casarett, Jason Karlawish, Pamela Sankar, Karen B. Hirschman & David A. Asch - 2001 - IRB: Ethics & Human Research 23 (4):1.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-799b6484c6-k4v55 uwo